Medicine guide

Pramipexol-Mepha 0.25 mg

As listed in the register: Pramipexol-Mepha 0.25 mg, Tabletten

0.25 mg ·

  • Prescription only
  • Pain, sleep, mood, epilepsy and the brain
Active substance
Pramipexolum
Made by
Mepha Pharma AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Morbus Parkinson, symptomatische Behandlung des idiopathischen Restless Legs Syndroms (RLS)

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byMepha Pharma AG
Active substancePramipexolum
Used inPain, sleep, mood, epilepsy and the brain
Strength0.25 mg
ClassificationN04BC05 · Pain, sleep, mood, epilepsy and the brain
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerPramipexol-Mepha 0.25 mg, Tabletten
Packs30 Tablette(n) · 100 Tablette(n)
Zulassungsnummer59149
Dosisstärke2

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.